Commercial National Financial Corp (Pennsylvania)
CNAF · OTC
About CNAF
- Employees
- 85
- Headquarters
- Latrobe, Pennsylvania
- Listed
- May 16, 1989
- Sector
- Financials
- Industry
- Banks
- Website
- cnbthebankonline.com
CNAF key statistics
- Market cap
- 23.83M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 4.07K
- Volume
- 21
- Open price
- $8.33
- High today
- $8.33
- Low today
- $8.33
- 52 Week high
- $9.40
- 52 Week low
- $7.51
Commercial National Financial Corp (Pennsylvania) (CNAF) at a glance
As of Oct 20, 2026, Commercial National Financial Corp (Pennsylvania) (CNAF) shares are priced at $8.33, giving the company a market cap of 23.83M and a price-to-earnings ratio of 0.00.
Volume so far is 21 shares, below the average of 4.07K shares a day.
Over the past year Commercial National Financial Corp (Pennsylvania) has ranged from $7.51 to $9.40, and now sits 43% of the way up that range.
Similar companies
Companies in the same industry as Commercial National Financial Corp (Pennsylvania)
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0899−4.36%
- SXTCChina SXT Pharmaceuticals$0.0653−41.28%
- OLOXOlenox Industries$0.737+5.18%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- RBNERobin Energy$0.3978−23.65%
- WFFWF Holding$0.0929−3.83%
- SDSTStardust Power$0.02−23.66%
- RCTRedCloud Holdings$0.084+1.94%
- DKIDarkiris$0.0479−6.08%
- AMODAlpha Modus Holdings$1.29+8.40%
- SPCXSpace Exploration Technologies$147.79−0.11%
- PPERFBank Mandiri (Persero) Tbk PT$0.2088
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.